Tradestie Institutional Equity Comparison Engine

ENSC vs KAVL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENSC Overall Edge

ENSC Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, ENSC trades at 0.8x Forward P/E with -281.3% operating margin (-15.1% YoY revenue) versus KAVL at N/M Forward P/E and -392.1% operating margin (-80.0% YoY). In options structure, ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KAVL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ENSC
ENSC 0.8x vs KAVL N/M Fwd P/E
Growth & Margin Winner ENSC
Op Margin -281.3% vs -392.1% ยท YoY -15.1% vs -80.0%
Momentum & Technical Winner ENSC
1Y -80.3% vs -83.9% ยท 52W Pos 8% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ENSC NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap $7.0M
1M Return -29.55%
1Y Return -80.33%
Forward P/E 0.8x
Unified AI Score
53.4 / 100 HOLD
Tech 50.0 Fund 62.0 Flow 50.0 Mom 60.0
KAVL NASDAQ
Kaival Brands Innovations Group, Inc
Retail-Nonstore Retailers
$0.14
-12.96% 1D
Market Cap $1.8M
1M Return -71.05%
1Y Return -83.86%
Forward P/E N/M
Unified AI Score
49.1 / 100 HOLD
Tech 40.0 Fund 49.0 Flow 50.0 Mom 63.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ENSC -80.33% KAVL -83.86% Spread: +35.81 pp (ENSC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ENSC Revenue KAVL Revenue ENSC Op. Margin KAVL Op. Margin Margin Edge
FY2020 $0M $60M -41.0% 2.8% KAVL
FY2021 $0M $60M -562.7% 6.8% KAVL
FY2022 $0M $10M -959.9% 35.3% KAVL
FY2023 $0M $10M -480.5% 181.9% KAVL
FY2024 $10M $10M -129.2% 432.7% KAVL
FY2025 $10M $0M -202.1% -3431.2% ENSC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ENSC (7) vs KAVL (2)
Institutional Metric ENSC KAVL Criterion Row Winner
Market Capitalization Scale $7.0M $1.8M Larger Scale Tie
Trailing P/E Ratio Valuation 0.8x N/M Lower Multiple ENSC
Forward P/E Ratio Valuation 0.8x N/M Lower Multiple ENSC
Revenue Growth (YoY) Growth -15.1% -80.0% Higher Growth ENSC
Operating Margin (TTM) Profitability -281.3% -392.1% Higher Margin ENSC
Net Profit Margin Profitability -280.5% 0.0% Higher Margin KAVL
Return on Equity (ROE) Capital Efficiency -1295.1% -68.6% Higher ROE KAVL
52-Week Range Position Momentum 8% ($0โ€“$2) 1% ($0โ€“$2) Stronger Trend ENSC
Beta / 30D Volatility Risk Regime 0.98ฮฒ ยท 79% Vol 0.88ฮฒ ยท 244% Vol Lower Realized Risk ENSC
Unified Institutional Score Composite Signal 53.4 / 100 (HOLD) 49.1 / 100 (HOLD) Higher Composite ENSC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ENSC vs KAVL Buy Guide
ENSC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ENSC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KAVL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KAVL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ENSC nor KAVL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.